Discuss the Impact of Changing Cannabis Policy With Adam Rosenberg, NCIA Board Chair

Monday, November 16, 2026

4:00 PM-5:00 PM

Inspired by the therapeutic potential of cannabis and its derivatives, Adam Rosenberg has dedicated his career to shaping the industry as an operator, investor, advisor, and educator across state-regulated cannabis, biopharmaceuticals, and hemp. He currently serves as the Chairman of the Board of the National Cannabis Industry Association. In biopharmaceuticals, Adam advises executives and manages investment funds for companies pursuing FDA approval for cannabis-derived therapeutics including AJNA BioSciences, DeFloria, Andira Pharmaceuticals, and Pure Green Pharmaceuticals.

As President of Vlasic Bioscience, a cannabis bioscience company, Adam has spearheaded a national strategy to expand safe, affordable access to cannabinoid-based therapeutics. Since 2016, he has operated cultivation, processing, and retail facilities while working with top cannabis research and investment firms, including Arcview Group and Tress Capital. Beyond the U.S., Adam has experience in global cannabis practices throughout the world, including three strain-hunting expeditions to the Himalayas in Nepal since 2018.

His passion for education and industry development was fostered at the University of Michigan Ross School of Business, where he founded Green Wolverine, the nation’s first student-led cannabis business organization. Since then, he has collaborated with leading academic institutions and continues to educate as a speaker at industry events and a lecturer in the University of Michigan’s PharmSci 420 Medicinal Cannabis Course.

Adam advocates for expanding safe access, advancing responsible regulation, and educating on nature’s power to improve lives.

RSVP

Contact Information

js4982@drexel.edu